Cyclophosphamide Injection, Powder, For Solution
Product Images NDC 65219-133

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Cyclophosphamide (NDC 65219-133). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Cyc0c 0000 01)

Chemical structure of cyclophosphamide, showing its molecular formula with characteristic elements including nitrogen, oxygen, and a phosphoramide group in a cyclic arrangement.*

FDA Label Image

Fresenius Kabi Logo (Cyc0c 0000 02)

FDA Label Image

Principal Display Panel – 500 mg/vial – Carton (Cyc0c 0000 03)

Packaging label for Cyclophosphamide for Injection, USP 500 mg/vial by Fresenius Kabi USA, LLC. The label includes dosing instructions for intravenous infusion and direct injection, storage conditions, and warns that the product is a cytotoxic agent. The product must be diluted before use, is single-dose, and the unused portion should be discarded. The label also displays the NDC 65219-135-20 and manufacturing details.*

FDA Label Image

Principal Display Panel – 500 mg/vial – Vial Label (Cyc0c 0000 04)

Label for Cyclophosphamide for Injection, USP, 500 mg per vial, powder for solution for intravenous use. The single-dose vial label includes preparation instructions for IV infusion and direct injection, storage conditions, and states the product is sterile and non-pyrogenic. Manufactured for Fresenius Kabi USA, LLC.*

FDA Label Image

Principal Display Panel – 1 Gram/vial – Carton (Cyc0c 0000 05)

Cyclophosphamide for Injection, USP 1 gram vial packaging label. The box is marked with instructions emphasizing dilution for intravenous infusion or direct injection and that it is a cytotoxic agent intended for single-dose use with unused portions discarded. The labeler is Fresenius Kabi USA, LLC. The label includes storage instructions and manufacturer information noting production in China.*

FDA Label Image

Principal Display Panel – 1 Gram/vial – Vial Label (Cyc0c 0000 06)

Cyclophosphamide for Injection, USP 1 gram per vial powder for solution label. This single-dose vial is indicated for intravenous use. The label states to add 50 mL sterile water or 0.9% sodium chloride for injection to dissolve the drug. It is sterile and non-pyrogenic, labeled as a cytotoxic agent, manufactured for Fresenius Kabi USA, LLC in Lake Zurich, IL.*

FDA Label Image

Principal Display Panel – 2 Gram/vial – Carton (Cyc0c 0000 07)

Packaging label for Cyclophosphamide for Injection, USP 2 gram/vial, a powder for solution indicated for intravenous infusion or direct injection use. The label highlights cytoxic agent warnings, single-dose vial instructions, and directs dilution before use. Manufactured by Fresenius Kabi USA, LLC, with details including storage instructions and dosage notes.*

FDA Label Image

Principal Display Panel – 2 Gram/vial – Vial Label (Cyc0c 0000 08)

Label for Cyclophosphamide for Injection, USP 2 gram/vial, an intravenous single-dose powder for solution. The label states instructions for reconstitution using sterile water or sodium chloride injection. It is labeled as a cytotoxic agent and manufactured for Fresenius Kabi USA, LLC, Lake Zurich, IL, with the product origin as China.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.